Science
Mechanism of Action
Lapachone (both alpha and beta isomers) promotes skin wound healing by significantly increasing the rate of cell migration during the proliferation phase. This is achieved through elevating the expression of critical cell migration-related proteins, including Cdc42, Rac1, Rho-A, and α-Pak. It also enhances skin regeneration by upregulating Sirt3 expression. Specifically, beta-lapachone further contributes to anti-aging by boosting collagen synthesis and acts as a depigmentation agent by inhibiting melanin synthesis and tyrosinase activity. This inhibition extends to reducing the expression of key melanogenesis factors: tyrosinase, tyrosinase-related protein-1 (TRP-1), and microphthalmia-associated transcription factor (MITF). Additionally, beta-lapachone exhibits notable anti-inflammatory and antioxidant properties. While its bioactivation by NAD(P)H:quinone oxidoreductase-1 (NQO1) to generate reactive oxygen species is a mechanism primarily studied for anticancer potential, it underscores the compound's significant biological activity.
Research
Clinical Evidence
Medium confidence0.05%
Key findings
- 01 Alpha-lapachone effectively promoted wound healing in mouse skin, showing an increased rate from day 4 onwards, enhancing cell migration and Sirt3 expression for skin regeneration.
- 02 Beta-lapachone stimulated the proliferation of fibroblasts, keratinocytes, and endothelial cells, contributing to enhanced wound healing activity.
- 03 Beta-lapachone inhibited melanin synthesis and tyrosinase activity in melan-a cells and reduced melanogenesis in human 3D skin tissue culture, demonstrating its potential as a depigmentation agent.
Transparency
Dusting Analysis
Despite promising preclinical data, Lapachone's current lack of comprehensive cosmetic safety review by bodies like CIR or SCCS, combined with its investigation as an anticancer drug, means it is not typically included in cosmetic formulations as a 'dusting' ingredient. Its potent biological activity suggests it would require thorough safety and efficacy validation for cosmetic use.
The Formula
Formulation
Stability
Beta-lapachone is highly photosensitive, with light exposure accelerating its degradation up to 140-fold faster than in darkness. It degrades more rapidly under basic (alkaline) pH conditions, exhibiting maximum stability within a narrow acidic pH range of 2-4. It is poorly soluble in water. Microencapsulation is a key strategy to enhance its stability, particularly photostability. While cyclodextrins can protect against hydrolytic degradation in darkness, they may paradoxically accelerate photolysis.
Conflicts
- magnesium stearate
- dicalcium phosphate dihydrate
- basic pH conditions
- light exposure
Safety
Safety Profile
No direct safety assessments from the Cosmetic Ingredient Review (CIR) or the Scientific Committee on Consumer Safety (SCCS) for Lapachone as a cosmetic ingredient have been identified. Beta-lapachone is actively being investigated in clinical trials as an anticancer drug, which signifies its potent pharmacological activity and mandates extensive safety scrutiny for cosmetic applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Lapachone demonstrates significant preclinical potential across various skin concerns, but comprehensive cosmetic safety assessments are critically needed before its broad recommendation or integration into formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources